9 months ago
GM mosquito trials raise concern in India
Bangalore/Chennai, July 23 - Experiments with genetically modified - mosquitoes planned in India by a British company in a move to find a way to control dengue fever have taken sections of the scientific community by surprise.
'I am trying to get full details about what is going on,' V.M. Katoch, secretary in the Department of Health Research and chief of the Indian Council of Medical Research - ...
read more
1 year ago
Scientists use E. coli to make drugs
Washington, Dec 23 - Researchers have turned to the lethal E. coli to synthesise a class of natural products known as bacterial aromatic polyketides - that include antibiotic and anti-cancer drugs.
BAPs include the antibiotic tetracycline and the compound doxorubicin, used in the treatment of breast and other cancers. Many of these natural products are synthesized by organisms that are difficult ...
read more
1 year ago
Scientists use E. coli to make drugs
Washington, Dec 23 - Researchers have turned to the lethal E. coli to synthesise a class of natural products known as bacterial aromatic polyketides - that include antibiotic and anti-cancer drugs.
BAPs include the antibiotic tetracycline and the compound doxorubicin, used in the treatment of breast and other cancers. Many of these natural products are synthesized by organisms that are difficult ...
read more
Bangalore
|
2 years ago
Andhra-born Indian scientist to be honoured
Bangalore, June 17 - The Indian government has decided to give a fitting tribute to a scientist from Andhra Pradesh who as a researcher in the US gave the world the antibiotic tetracycline that has saved millions of lives in the last 50 years.The Indian Council of Medical research - is to set up a new building in the campus of the National Institute of Nutrition - in Hyderabad to house the entire ...
read more
4 years ago
Cedars-Sinai researchers demonstrate a new way to switch therapeutic genes 'on'
Although other similar signaling systems have been developed, the Cedars-Sinai research is the first to give physicians the flexibility to arbitrarily turn the gene expression on or off even in the presence of an immune response to adenovirus, as would be present in most patients undergoing clinical trials. This has been a major obstacle in bringing the testing of genetic therapies to humans in a ...
read more
4 years ago
Scientists engineer mice to mimic Alzheimer's therapy
The development, reported Nov. 15 in the international open-access medical journal PloS Medicine, has helped scientists evaluate the brain's ability to repair one of Alzheimer's hallmark lesions, senile plaque. These plaques occur when enzymes - proteins that cause or speed up chemical reactions - create peptide fragments called beta amyloid, also known as Abeta. The fragments clump together to fo ...
read more
4 years ago
Timing possible treatments against Alzheimer's disease
As they report in the international open-access medical journal PLoS Medicine, they have engineered mice to continuously produce Abeta in their brains. The production can be switched off by giving the mice the antibiotic tetracycline in their drinking water. This switch-off at a certain point is similar to what would happen to human patients who would receive enzyme inhibitors once diagnosed with ...
read more
|
